Aurobindo Pharma Reports Steady Profit Growth Driven by Domestic and Global Demand
Aurobindo Pharma has reported a rise in profit for the second quarter of the financial year, reflecting steady domestic demand
Read More
Factual Version of a Story
North America pharma market